|
In order to view this program you must log in. If you do not have an account, please register for one.
Viewing the webcast requires use of the free RealPlayer. 
If you are having problems viewing the program, please check out our technical support section.
|
| Credits | 1.00 |
| Release Date | 3/13/2009 |
| Termination Date | 3/13/2012 |
| Cost |
$25.00 to view the program and complete a post test for CME credit. To purchase this program please log in.
|
| Description | According to the National Institutes of Health, In the United States, colon cancer is the fourth most common cancer in men and women. When caught early, it is often curable. This program is supported in part by educational grants from Merck and Astellas.
View the NCCN Colon Cancer Guidelines (PDF file, Adobe Acrobat required).
|
| Accreditation Statement | The Ohio State University Medical Center, Center for Continuing Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The Ohio State University Medical Center designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. |
| Author | Maher Azzouz, MD and Tanios Bekaii-Saab, MD |
| Objectives | Upon completion of this educational activity, the participant should be able to: 1.) Describe current advances in the selection of treatment strategies for patients with stages II and III colorectal cancer. 2.)Describe the role of integrating biologics to cytotoxics in the treatment of stage IV colorectal cancer. 3.) Review the current screening guidelines for colorectal cancer screening 4.) Review the pathogenesis and genetics of colon carcinogenesis |
| Audience | This course is designed for physicians. |
| Estimated Time to Complete | 1 Hour |
